N. Kobayashi et al., Expansion of human hepatocyte populations by a retroviral gene transfer ofsimian virus 40 large T antigen, ASAIO J, 47(5), 2001, pp. 481-485
A hybrid artificial liver (HAL) could be used to treat acute liver failure
or to serve as a temporary support until orthotopic liver transplantation i
s available. Primary human hepatocytes are ideal as a source of hepatic fun
ction in a HAL device. However, the worldwide shortage of human livers avai
lable for hepatocyte isolation severely limits this form of therapy. A poss
ible alternative is to use a tightly regulated cell line that can be econom
ically grown in culture to have differentiated liver function. In this work
, human hepatocytes were immortalized with a retroviral vector SSR#69 expre
ssing the genes of simian virus 40 large T antigen and herpes simplex virus
-thymidine kinase. One of the resulting clones, NKNT-3, showed the gene exp
ression of differentiated liver function and were sensitive to the antivira
l agent ganciclovir. When transplanted into the spleen of rats subjected to
90% hepatectomy, NKNT-3 cells prolonged the survival of 90% hepatectomized
rats. The cells provide the advantages of unlimited availability, sterilit
y, uniformity, and freedom from pathogens. This work represents a potential
novel strategy for resolving the organ shortage that currently limits the
use of primary human hepatocytes to develop a HAL.